ArticleJournal of translational medicine2014

Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

Francesca Tavano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.